Appendix Table D-1Local therapies for colorectal cancer metastases to the liver, study quality Carey and Boden Case Series quality Assessment

ReferenceClearly Defined QuestionWell-Described Study PopulationWell-Described InterventionUse of Validated Outcome MeasuresAppropriate Statistical AnalysisWell-Described ResultsDiscussion/Conclusions Supported by DataRank*
Albert – 2011YesNoYesYesYesYesYesFair
Aliberti – 2011YesYesYesYesYesYesYesGood
Cianni – 2009YesNoYesYesYesYesYesFair
Cosimelli - 2010YesYesYesYesYesYesYesGood
Fiorentini – 2007YesNoYesYesYesNoYesPoor
Hong – 2009YesYesYesYesYesYesYesGood
Jakobs – 2006YesYesYesYesYesYesYesGood
Jakobs – 2008YesNoYesYesYesYesYesFair
Jiao – 2007YesNoYesYesYesNoYesPoor
Kim – 2009YesYesYesYesYesYesYesGood
Kucuk – 2011YesNoYesYesYesYesYesFair
Lewandowski – 2005YesYesYesYesYesYesYesGood
Lim – 2005YesNoYesYesYesNoYesPoor
Martin – 2011YesYesYesYesYesYesYesGood
Martin – 2012YesNoYesYesYesYesYesFair
Mulcahy - 2009YesYesYesYesYesYesYesGood
Nace – 2011YesNoYesYesYesYesYesFair
Nishiofuku - 2010YesYesYesYesYesYesYesGood
Rowe - 2007YesYesYesYesYesYesYesGood
Sato - 2008YesNoYesYesYesYesYesFair
Stintzing – 2010YesNoYesYesYesYesYesFair
Vautravers-Dewas - 2011YesYesYesYesYesYesYesGood
Vogl - 2008YesNoYesYesYesYesYesFair
*

A rank of good indicates that all Carey and Boden critera are fulfilled, a rank of fair indicates that one criterion was unfulfilled or it was not possible to assess a criterion given the published information, a rank of poor indicates that two or more criteria were unfulfilled or it was not possible to assess two or more criteria given the published information.

From: Appendix D, Evidence Tables

Cover of Local Hepatic Therapies for Metastases to the Liver From Unresectable Colorectal Cancer
Local Hepatic Therapies for Metastases to the Liver From Unresectable Colorectal Cancer [Internet].
Comparative Effectiveness Reviews, No. 93.
Belinson S, Chopra R, Yang Y, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.